Results 61 to 70 of about 1,093,427 (365)

Expression of CXCL10 is associated with response to radiotherapy and overall survival in squamous cell carcinoma of the tongue [PDF]

, 2014
Five-year survival for patients with oral cancer has been disappointingly stable during the last decades, creating a demand for new biomarkers and treatment targets.
Philip John Coates, Torben Wilms, Laurell, Göran,, Rentoft, Matilda,, Coates, Philip John, Matilda Rentoft, Lotta Loljung, Göran Laurell, Karin Nylander, Rentoft, Matilda, Laurell, Göran, Wilms, Torben, Loljung, Lotta, Nylander, Karin, Loljung, Lotta,, Wilms, Torben,, Nylander, Karin,, Coates, Philip John,   +17 more
core   +1 more source

Venous Thromboembolism in Pediatric Bone Sarcoma Patients: A 10‐Year, Single‐Institution Experience Encompassing the COVID‐19 Pandemic

Pediatric Blood &Cancer, EarlyView.
ABSTRACT Background Osteosarcoma (OS) and Ewing sarcoma (EWS) are the most common primary bone cancers in children, but acute thrombosis is poorly characterized in this population. Our study evaluated the rates of venous thromboembolism (VTE) and associated risk factors in pediatric patients with bone sarcomas treated over a 10‐year period encompassing
Sarah Kappa, Shou Xu, Mark Zobeck, Sarah E. Sartain, Nino Rainusso, Lisa Wang, Nicole Montgomery, Paige Wheaton, Sarah Whittle   +8 more
wiley   +1 more source

Multicatheter interstitial brachytherapy versus stereotactic radiotherapy with CyberKnife for accelerated partial breast irradiation: a comparative treatment planning study with respect to dosimetry of organs at risk

Radiology and Oncology, 2021
The aim of the study was to dosimetrically compare multicatheter interstitial brachytherapy (MIBT) and stereotactic radiotherapy with CyberKnife (CK) for accelerated partial breast irradiation (APBI) especially concerning the dose of organs at risk (OAR ...
Herein András, Stelczer Gábor, Pesznyák Csilla, Fröhlich Georgina, Smanykó Viktor, Mészáros Norbert, Polgár Csaba, Major Tibor   +7 more
doaj   +1 more source

Profile of European radiotherapy departments contributing to the EORTC Radiation Oncology Group (ROG) in the 21st century

, 2008
Since 1982, the Radiation Oncology Group of the EORTC (EORTC ROG) has pursued an extensive Quality Assurance (QA) program involving all centres actively participating in its clinical research.
Collette, L., Budiharto, Tom, Hurkmans, Coen, Aird, Edwin, Musat, Elena, Duclos, F., Davis, Bernard, Poortmans, P., Aird, E., Monti, A., Monti, Angelo, Musat, E., Collette, Laurence, Bar-Deroma, R., Davis, B., Bernstein, Zvi, van Tienhoven, Geertjan, Poortmans, Philip, Tienhoven, G., Hurkmans, C., Bar-Deroma, Raquel, Duclos, Frédéric, Bernstein, Z., Budiharto, T.   +23 more
core   +1 more source

Data for TROTS – The Radiotherapy Optimisation Test Set [PDF]

, 2017
The Radiotherapy Optimisation Test Set (TROTS) is an extensive set of problems originating from radiotherapy (radiation therapy) treatment planning. This dataset is created for 2 purposes: (1) to supply a large-scale dense dataset to measure performance ...
Heijmen, B.J.M. (Ben), Ben Heijmen, Heijmen, Ben, Breedveld, S. (Sebastiaan), Breedveld, Sebastiaan, Sebastiaan Breedveld, Breedveld, Sebastiaan; id_orcid   +6 more
core   +1 more source

Serological Benefit of SARS‐CoV‐2 Vaccination Relative to Infection in Children With Acute Lymphoblastic Leukemia

Pediatric Blood &Cancer, EarlyView.
ABSTRACT Background Children with acute lymphoblastic leukemia (ALL) are at risk of severe outcomes from SARS‐CoV‐2 (SCV2). In the post‐pandemic context, where most children have been infected with SCV2, there are limited data on whether vaccination remains beneficial in children with ALL.
Janna R. Shapiro, Freda Qi, Karen Colwill, Alina D. Dorogy, Ying Liu, Michelle Science, Anne‐Claude Gingras, James M. Rini, Sumit Gupta, Sarah Alexander, Shelly Bolotin, Tania H. Watts   +11 more
wiley   +1 more source

Radiotherapy to the primary tumour for newly diagnosed, metastatic prostate cancer (STAMPEDE): a randomised controlled phase 3 trial

The Lancet, 2018
Summary Background Based on previous findings, we hypothesised that radiotherapy to the prostate would improve overall survival in men with metastatic prostate cancer, and that the benefit would be greatest in patients with a low metastatic burden.
David P Gillessen, Silke Gilson, C. Jones, Robert J Langley, R. Malik, C. Parker, N. James, C. Brawley, N. Clarke, A. Hoyle, Adnan Ali, A. Ritchie, G. Attard, S. Chowdhury, W. Cross, D. Dearnaley, S. Gillessen, C. Gilson, Robert J. Jones, R. Langley, Z. Malik, M. Mason, D. Matheson, R. Millman, J. Russell, G. Thalmann, C. Amos, R. Alonzi, A. Bahl, A. Birtle, O. Din, H. Douis, C. Eswar, J. Gale, M. Gannon, S. Jonnada, S. Khaksar, J. Lester, J. O’Sullivan, O. Parikh, I. Pedley, D. Pudney, D. Sheehan, N. Srihari   +43 more
semanticscholar   +1 more source

Deep Sequencing of FLT3‐ITD Enables Response Evaluation and Post‐Treatment Monitoring in Childhood AML: An Exploratory Study

Pediatric Blood &Cancer, EarlyView.
ABSTRACT Background An internal tandem duplication in the gene encoding Fms‐like tyrosine kinase 3 (FLT3‐ITD) is associated with high relapse risk and poor prognosis in acute myeloid leukemia (AML) and plays a crucial role in treatment decisions. Measurable residual disease (MRD) analysis of FLT3‐ITD during and after treatment has shown prognostic ...
Sofie Johansson Alm, Bea Tornberg, Erik Delsing Malmberg, Henrik Hasle, Kristian Løvvik Juul‐Dam, Lars Palmqvist, Borhan R. Saeed, Giti Shah Barkhordar, Anastasia Soboli, Anna Staffas, Jonas Abrahamsson, Linda Fogelstrand   +11 more
wiley   +1 more source

Test of association between variant TG?1 alleles and late adverse effects of breast radiotherapy

, 2010
Purpose: to test for association between single nucleotide polymorphisms at the TGF?1 locus and the risk of late normal tissue injury following whole breast radiotherapy.Methods: a retrospective study compared the number of variant alleles at ?509 and ...
Haviland, J.S., Martin, S., Sydenham, M., A'Hern, R., Yarnold, J., Owen, R., Bliss, J.   +6 more
core   +1 more source

Claudin‐6 Protein Expression in Atypical Teratoid/Rhabdoid Tumors Is Strongly Enriched in the Molecular Subgroup AT/RT‐TYR

Pediatric Blood &Cancer, EarlyView.
ABSTRACT Claudin‐6 has emerged as a promising immunotherapeutic target, yet protein‐level data in atypical teratoid/rhabdoid tumors (AT/RTs) have been inconsistent. We analyzed 36 well‐characterized AT/RT samples and found membranous claudin‐6 protein expression in 58% of cases, with striking enrichment in the molecular subgroup AT/RT‐TYR (100%) and ...
Victoria E. Fincke, Christian Thomas, Michael C. Frühwald, Pascal D. Johann, Martin Hasselblatt   +4 more
wiley   +1 more source